U.S. Gene Amplification Technologies Market Size & Outlook
U.S. gene amplification technologies market, 2018-2028 (US$M)
Related Markets
U.S. gene amplification technologies market highlights
- The U.S. gene amplification technologies market generated a revenue of USD 10,796.8 million in 2021 and is expected to reach USD 10,245.9 million by 2028.
- The U.S. market is expected to grow at a CAGR of -0.7% from 2022 to 2028.
- In terms of segment, pcr-based amplification was the largest revenue generating technology in 2021.
- Loop Mediated Isothermal Amplification (LAMP) is the most lucrative technology segment registering the fastest growth during the forecast period.
Gene amplification technologies market data book summary
| Market revenue in 2021 | USD 10,796.8 million |
| Market revenue in 2028 | USD 10,245.9 million |
| Growth rate | -0.7% (CAGR from 2021 to 2028) |
| Largest segment | Pcr-based amplification |
| Fastest growing segment | Loop Mediated Isothermal Amplification (LAMP) |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | PCR-based Amplification, Loop Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA), Strand Displacement Amplification (SDA), Multiple displacement amplification (MDA), Rolling Circle Amplification (RCA), Ramification amplification method (RAM) |
| Key market players worldwide | Qiagen NV, Illumina Inc, Bio-Rad Laboratories Inc, Silicon Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, Danaher Corp, New England Biolabs, 4Basebio, LGC Group, Vazyme Biotech, MyBiosource |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.6% of the global gene amplification technologies market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In North America, U.S. gene amplification technologies market is projected to lead the regional market in terms of revenue in 2028.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,178.5 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gene Amplification Technologies Market Scope
Gene Amplification Technologies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. gene amplification technologies market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene amplification technologies market will help companies and investors design strategic landscapes.
Pcr-based amplification was the largest segment with a revenue share of 90.63% in 2021. Horizon Databook has segmented the U.S. gene amplification technologies market based on pcr-based amplification, loop mediated isothermal amplification (lamp), nucleic acid sequence based amplification (nasba), strand displacement amplification (sda), multiple displacement amplification (mda), rolling circle amplification (rca), ramification amplification method (ram) covering the revenue growth of each sub-segment from 2018 to 2028.
Several public and private organizations in the U.S. offer kits, reagents, and instruments as well as services for various applications such as exome sequencing, whole-genome sequencing, and others. For instance, a research paper was published in June 2020 that demonstrated the application of rolling circle amplification for synthetic DNA.
This method enabled comparable biocatalytic activity to cell based workflows in approximately half a time. Thus, this method provided a promising alternative to conventional methods. Moreover, academic and research institutes engaged in genomic research are one of the major end users of these products thereby supporting the country’s market growth.
On the other hand, PCR is one of the widely used amplification methods in the country. The recent outbreak of the SARS-CoV-2 virus has resulted in the development of several PCR based diagnostic tests by several companies. This is expected to drive the U.S. market for gene amplification technologies.
Reasons to subscribe to U.S. gene amplification technologies market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. gene amplification technologies market databook
-
Our clientele includes a mix of gene amplification technologies market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. gene amplification technologies market , including forecasts for subscribers. This country databook contains high-level insights into U.S. gene amplification technologies market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. gene amplification technologies market size, by technology, 2018-2028 (US$M)
U.S. Gene Amplification Technologies Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
